Presatovir

Presatovir (GS-5806) is an antiviral drug which was developed as a treatment for respiratory syncytial virus.^[1][2] It acts as a fusion inhibitor, and has shown promising results in Phase II clinical trials.^[3][4]

Presatovir

Clinical data
Trade names	Presatovir
Legal status
Legal status	US: Investigational New Drug
Identifiers
IUPAC name N-[2-[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide
CAS Number	1353625-73-6
PubChem CID	58029842
UNII	9628AJ27JA
Chemical and physical data
Formula	C24H30ClN7O3S
Molar mass	532.06 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1=CN2C(=CC(=N2)[C@@H]3CCCCN3C(=O)C4=C(C=CC(=C4)Cl)NS(=O)(=O)C)N=C1N5CC[C@@H](C5)N
InChI InChI=1S/C24H30ClN7O3S/c1-15-13-32-22(27-23(15)30-10-8-17(26)14-30)12-20(28-32)21-5-3-4-9-31(21)24(33)18-11-16(25)6-7-19(18)29-36(2,34)35/h6-7,11-13,17,21,29H,3-5,8-10,14,26H2,1-2H3/t17-,21-/m0/s1 Key:GOFXWTVKPWJNGD-UWJYYQICSA-N

See also

• Palivizumab
• Lumicitabine
• Ziresovir